Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05863676 · ClinicalTrials.gov registry record
Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy
A clinical trial of Gender Dysphoria and Transgender, sponsored by University of Pittsburgh.
- Active
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05863676: Active study of Gender Dysphoria and Transgender, sponsored by University of Pittsburgh.
NCT05863676 is a study of Gender Dysphoria and Transgender that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 20 participants, below the 176-participant average among 8 other Gender Dysphoria trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05863676, a study of Gender Dysphoria and Transgender, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn about fertility preservation in the gender-diverse community. The main objectives it aims to understand are to: 1. To optimize techniques for cryopreservation of ovarian tissues, including determining efficacy of cryopreservation techniques. 2. To investigate factors affecting ovarian tissue and follicles, such as previous treatment with leuprolide acetate, or hormone therapy
Primary Outcome
Without undergoing puberty in one's natal sex, there are no standard of care fertility preservation options available for these patients. The study will aim to optimize techniques for cryopreservation of ovarian tissues by utilizing the best scientific standards for cryopreservation.
Conditions Studied
Interventions
- PROCEDURE Oophorectomy
- DIAGNOSTIC_TEST Infectious Disease Testing
Study Locations (1)
Pennsylvania
- Magee-Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-07-14 |
| Est. Completion | 2030-07 |
What the registry record for NCT05863676 still lists
NCT05863676 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 176-participant average among 8 other Gender Dysphoria trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Gender Dysphoria appearing as the primary indexed condition, and to 2 interventions - of which Oophorectomy is the first listed.
NCT05863676 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05863676 about?
NCT05863676 is a clinical study titled "Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy". The goal of this study is to learn about fertility preservation in the gender-diverse community. The main objectives it aims to understand are to: 1. To optimize techniques for cryopreservation of ovarian tissues, including determining efficacy of cryopreservation techniques. 2. To investigate fact...
What is the current status of trial NCT05863676?
This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2020-07-14. Estimated completion is 2030-07.
What conditions does trial NCT05863676 study?
This clinical trial studies the following conditions: Gender Dysphoria, Transgender.
What interventions are being tested in trial NCT05863676?
The interventions under investigation include: Oophorectomy (PROCEDURE), Infectious Disease Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05863676?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05863676 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gender Dysphoria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05863676's enrollment target sits among peer trials
20 8th of 8 higher than 1 of 8 other Gender Dysphoria trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gender Dysphoria trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
RECRUITING
-
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
RECRUITING · NA
-
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
RECRUITING · Phase 3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Effect of Nitropaste in Chest Masculinizing Surgery
RECRUITING · Phase 4
-
Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI